Try our Advanced Search for more refined results
September 20, 2010
Schueneman v. Arena Pharmaceuticals, Inc. et al
Case Number:
3:10-cv-01959
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Cooley LLP
- Donahue Fitzgerald
- Gibbs Law Group
- Girard Sharp
- Hulett Harper
- Kaplan Fox
- Kessler Topaz
- Lieff Cabraser
- MoginRubin
- Wolf Haldenstein
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
November 08, 2017
Arena Pharma, Investors Strike $24M Deal In Diet Drug Suit
Arena Pharmaceuticals Inc. has reached a $24 million cash-and-stock deal with a proposed class of investors to settle its seven-year battle in California federal court over allegations the company lied to shareholders that testing was going smoothly for its diet drug lorcaserin, which is sold under the trade name Belviq.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login